 |
Journal articles
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
O. Tredan
1
C. Menetrier-Caux
2
Isabelle Ray-Coquard
1
G. Garin
C. Cropet
E. Verronese
Thomas Bachelot
1
P. Rebattu
E. Heudel
1
Pierre Cassier
Sylvie Chabaud
T. Croughs
Pierre Dupont
C. Cadore
G. Clapisson
A. Delgado
3
C. Bardin-Dit-Courageot
C. Rigal
A. N'Kodia
L. Gilles-Afchain
M. Morre
David Perol
1
J.Y. Blay
1
Christophe Caux
4
Pierre Dupont
Author Employer institution : Université Lumière - Lyon 2
C. Cadore
Author
G. Clapisson
Author
A. Delgado 3
Author
1
Centre Léon Bérard [Lyon] (28, rue Laennec 69373 LYON Cedex 08 - France)
3
Universidad de Alicante (Carretera San Vicente del Raspeig s/n 03690 San Vicente del Raspeig - Alicante - Spain)
4
UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon (28, rue Laennec - 69373 Lyon - France)
- Centre Léon Bérard [Lyon] (28, rue Laennec 69373 LYON Cedex 08 - France)
- UCBL - Université Claude Bernard Lyon 1 (43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex - France)
- Université de Lyon (92 rue Pasteur - CS 30122, 69361 Lyon Cedex 07 - France)
- CNRS - Centre National de la Recherche Scientifique : UMR5286 (France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1052 (101, rue de Tolbiac, 75013 Paris - France)
Document type :
Journal articles
Domain :
Complete list of metadata
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795705
Contributor : Lauriane Pillet Connect in order to contact the contributor
Submitted on : Friday, May 18, 2018 - 4:38:39 PM
Last modification on : Wednesday, November 3, 2021 - 4:35:08 AM
Contributor : Lauriane Pillet Connect in order to contact the contributor
Submitted on : Friday, May 18, 2018 - 4:38:39 PM
Last modification on : Wednesday, November 3, 2021 - 4:35:08 AM
Links full text
Identifiers
- HAL Id : hal-01795705, version 1
- DOI : 10.1093/annonc/mdx058
- PUBMED : 28368453
Collections
UNIV-LYON1 | CNRS | CRCL | UDL
Citation
O. Tredan, C. Menetrier-Caux, Isabelle Ray-Coquard, G. Garin, C. Cropet, et al.. ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. Annals of Oncology, Elsevier, 2017, ⟨10.1093/annonc/mdx058⟩. ⟨hal-01795705⟩
Metrics
Les métriques sont temporairement indisponibles